Literature DB >> 14272501

THE PHARMACOTHERAPY OF THE DEPRESSIVE SYNDROME.

H E LEHMANN.   

Abstract

THREE THERAPEUTIC MODALITIES HAVE PROVED EFFECTIVE IN THE TREATMENT OF DEPRESSIVE SYNDROMES: electroconvulsive therapy (ECT), pharmacotherapy and psychotherapy. ECT gives the most reliable and most rapid results but may be contraindicated in certain cases. Psychotherapy is limited in its application to the reactive aspects of a depression. Pharmacotherapy is currently the most widely applied treatment of depression. Two classes of drugs are available which are effective in about 60% of depressed patients: the monoamine oxidase inhibitors and tricyclic compounds. Their mechanism of action is probably related to the regulation of the biogenic amine balance in the brain. The distinction between antipsychotic and antidepressant drugs is not as sharp as was formerly assumed. Maintenance pharmacotherapy has been shown to have prophylactic value in preventing relapses.

Entities:  

Keywords:  AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; DESIPRAMINE; DRUG THERAPY; IMIPRAMINE; MENTAL DISORDERS; MONOAMINE OXIDASE INHIBITORS; PSYCHOPHARMACOLOGY; REVIEW; SHOCK THERAPY, ELECTRIC; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS

Mesh:

Substances:

Year:  1965        PMID: 14272501      PMCID: PMC1927981     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  23 in total

1.  [PRESENT STATUS AND FUTURE POSSIBILITIES OF PHARMACOLOGICAL TREATMENT OF DEPRESSION].

Authors:  P KIELHOLZ
Journal:  Nervenarzt       Date:  1963-04       Impact factor: 1.214

2.  A HYPERTENSIVE SYNDROME WITH TRANYLCYPROMINE MEDICATION.

Authors:  A J COOPER; R V MAGNUS; M J ROSE
Journal:  Lancet       Date:  1964-03-07       Impact factor: 79.321

3.  TEMPORAL FACTORS IN DEPRESSIVE ILLNESSES.

Authors:  J E OLTMAN; S FRIEDMAN
Journal:  Dis Nerv Syst       Date:  1963-11

4.  [CHEMICAL STRUCTURE AND CLINICAL EFFECT OF ANTIDEPRESSIVE DRUGS].

Authors:  D BENTE; H HIPPIUS; W POELDINGER; K STACH
Journal:  Arzneimittelforschung       Date:  1964-06

5.  [RESULTS AND PROBLEMS OF CLINICAL EXPERIMENTAL STUDIES ON THE METABOLISM OF BIOGENIC AMINES].

Authors:  N A TAUTZ; E SCHMID; D BENTE
Journal:  Arzneimittelforschung       Date:  1964-06

6.  [EFFECT OF ANTIDEPRESSIVES AND GENETIC FACTORS].

Authors:  J ANGST
Journal:  Arzneimittelforschung       Date:  1964-06

7.  Quantitative comparisons of the electroencephalographic stimulant effects of deanol, choline, and amphetamine.

Authors:  C C PFEIFFER; L GOLDSTEIN; C MUNOZ; H B MURPHREE; E H JENNEY
Journal:  Clin Pharmacol Ther       Date:  1963 Jul-Aug       Impact factor: 6.875

8.  [Clinical experiences with thioridazine (Melleril-Sandoz) based on 202 cases, with a contribution to the problem of treatment of endogenous depressions].

Authors:  A BAUER
Journal:  Nervenarzt       Date:  1962-07       Impact factor: 1.214

9.  The independence of neurotic depression and endogenous depression.

Authors:  L G KILOH; R F GARSIDE
Journal:  Br J Psychiatry       Date:  1963-07       Impact factor: 9.319

10.  Combined pharmaco-fever treatment with imipramine (tofranil) and typhoid vaccine in the management of depressive conditions.

Authors:  H E LEHMANN
Journal:  Am J Psychiatry       Date:  1960-10       Impact factor: 18.112

View more
  2 in total

Review 1.  The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.

Authors:  Eleni Pitsillou; Sarah M Bresnehan; Evan A Kagarakis; Stevano J Wijoyo; Julia Liang; Andrew Hung; Tom C Karagiannis
Journal:  Mol Biol Rep       Date:  2019-10-14       Impact factor: 2.316

2.  A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat.

Authors:  S S Kety; F Javoy; A M Thierry; L Julou; J Glowinski
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.